Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-60,204
Closed -$3.92M 263
2020
Q1
$3.92M Sell
60,204
-4,651
-7% -$366K 1.19% 23
2019
Q4
$5.11M Sell
64,855
-423
-0.6% -$32.9K 1.21% 23
2019
Q3
$5.2M Buy
65,278
+606
+0.9% +$47.6K 1.28% 17
2019
Q2
$5.41M Sell
64,672
-352
-0.5% -$28K 1.3% 17
2019
Q1
$5.14M Sell
65,024
-602
-0.9% -$43.9K 1.25% 17
2018
Q4
$4.38M Buy
+65,626
New +$4.54M 1.22% 15

Other funds holding XYL

Stanley-Laman Group's XYL Position: Q2 2020 in Review

Stanley-Laman Group sold out of Xylem (XYL) in Q2 2020, closing a stake of 60,204 shares — an estimated $3.92M sold.

Stanley-Laman Group first reported a position in XYL in Q4 2018 and held it in 6 quarters. The position peaked at $5.41M in Q2 2019. 645 funds tracked by Wall St. Rank hold XYL as of Q2 2020.

  • Stanley-Laman Group reported no remaining Xylem position as of Q2 2020 after selling out during the quarter.
  • Stanley-Laman Group sold 60,204 Xylem shares in Q2 2020, an estimated $3.92M.
  • Stanley-Laman Group first reported a position in Xylem in Q4 2018 and held it in 6 quarters.
  • Stanley-Laman Group's Xylem position peaked at $5.41M in Q2 2019.
  • 645 funds tracked by Wall St. Rank held Xylem as of Q2 2020.

Based on Stanley-Laman Group's 13F filing for Q2 2020, filed 20 Jul 2020.